Cargando…

Cryptic-site binding mechanism of medium-sized Bcl-xL inhibiting compounds elucidated by McMD-based dynamic docking simulations

We have performed multicanonical molecular dynamics (McMD) based dynamic docking simulations to study and compare the binding mechanism between two medium-sized inhibitors (ABT-737 and WEHI-539) that bind to the cryptic site of Bcl-xL, by exhaustively sampling the conformational and configurational...

Descripción completa

Detalles Bibliográficos
Autores principales: Bekker, Gert-Jan, Fukuda, Ikuo, Higo, Junichi, Fukunishi, Yoshifumi, Kamiya, Narutoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930018/
https://www.ncbi.nlm.nih.gov/pubmed/33658550
http://dx.doi.org/10.1038/s41598-021-84488-z
_version_ 1783660025118457856
author Bekker, Gert-Jan
Fukuda, Ikuo
Higo, Junichi
Fukunishi, Yoshifumi
Kamiya, Narutoshi
author_facet Bekker, Gert-Jan
Fukuda, Ikuo
Higo, Junichi
Fukunishi, Yoshifumi
Kamiya, Narutoshi
author_sort Bekker, Gert-Jan
collection PubMed
description We have performed multicanonical molecular dynamics (McMD) based dynamic docking simulations to study and compare the binding mechanism between two medium-sized inhibitors (ABT-737 and WEHI-539) that bind to the cryptic site of Bcl-xL, by exhaustively sampling the conformational and configurational space. Cryptic sites are binding pockets that are transiently formed in the apo state or are induced upon ligand binding. Bcl-xL, a pro-survival protein involved in cancer progression, is known to have a cryptic site, whereby the shape of the pocket depends on which ligand is bound to it. Starting from the apo-structure, we have performed two independent McMD-based dynamic docking simulations for each ligand, and were able to obtain near-native complex structures in both cases. In addition, we have also studied their interactions along their respective binding pathways by using path sampling simulations, which showed that the ligands form stable binding configurations via predominantly hydrophobic interactions. Although the protein started from the apo state, both ligands modulated the pocket in different ways, shifting the conformational preference of the sub-pockets of Bcl-xL. We demonstrate that McMD-based dynamic docking is a powerful tool that can be effectively used to study binding mechanisms involving a cryptic site, where ligand binding requires a large conformational change in the protein to occur.
format Online
Article
Text
id pubmed-7930018
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-79300182021-03-04 Cryptic-site binding mechanism of medium-sized Bcl-xL inhibiting compounds elucidated by McMD-based dynamic docking simulations Bekker, Gert-Jan Fukuda, Ikuo Higo, Junichi Fukunishi, Yoshifumi Kamiya, Narutoshi Sci Rep Article We have performed multicanonical molecular dynamics (McMD) based dynamic docking simulations to study and compare the binding mechanism between two medium-sized inhibitors (ABT-737 and WEHI-539) that bind to the cryptic site of Bcl-xL, by exhaustively sampling the conformational and configurational space. Cryptic sites are binding pockets that are transiently formed in the apo state or are induced upon ligand binding. Bcl-xL, a pro-survival protein involved in cancer progression, is known to have a cryptic site, whereby the shape of the pocket depends on which ligand is bound to it. Starting from the apo-structure, we have performed two independent McMD-based dynamic docking simulations for each ligand, and were able to obtain near-native complex structures in both cases. In addition, we have also studied their interactions along their respective binding pathways by using path sampling simulations, which showed that the ligands form stable binding configurations via predominantly hydrophobic interactions. Although the protein started from the apo state, both ligands modulated the pocket in different ways, shifting the conformational preference of the sub-pockets of Bcl-xL. We demonstrate that McMD-based dynamic docking is a powerful tool that can be effectively used to study binding mechanisms involving a cryptic site, where ligand binding requires a large conformational change in the protein to occur. Nature Publishing Group UK 2021-03-03 /pmc/articles/PMC7930018/ /pubmed/33658550 http://dx.doi.org/10.1038/s41598-021-84488-z Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Bekker, Gert-Jan
Fukuda, Ikuo
Higo, Junichi
Fukunishi, Yoshifumi
Kamiya, Narutoshi
Cryptic-site binding mechanism of medium-sized Bcl-xL inhibiting compounds elucidated by McMD-based dynamic docking simulations
title Cryptic-site binding mechanism of medium-sized Bcl-xL inhibiting compounds elucidated by McMD-based dynamic docking simulations
title_full Cryptic-site binding mechanism of medium-sized Bcl-xL inhibiting compounds elucidated by McMD-based dynamic docking simulations
title_fullStr Cryptic-site binding mechanism of medium-sized Bcl-xL inhibiting compounds elucidated by McMD-based dynamic docking simulations
title_full_unstemmed Cryptic-site binding mechanism of medium-sized Bcl-xL inhibiting compounds elucidated by McMD-based dynamic docking simulations
title_short Cryptic-site binding mechanism of medium-sized Bcl-xL inhibiting compounds elucidated by McMD-based dynamic docking simulations
title_sort cryptic-site binding mechanism of medium-sized bcl-xl inhibiting compounds elucidated by mcmd-based dynamic docking simulations
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930018/
https://www.ncbi.nlm.nih.gov/pubmed/33658550
http://dx.doi.org/10.1038/s41598-021-84488-z
work_keys_str_mv AT bekkergertjan crypticsitebindingmechanismofmediumsizedbclxlinhibitingcompoundselucidatedbymcmdbaseddynamicdockingsimulations
AT fukudaikuo crypticsitebindingmechanismofmediumsizedbclxlinhibitingcompoundselucidatedbymcmdbaseddynamicdockingsimulations
AT higojunichi crypticsitebindingmechanismofmediumsizedbclxlinhibitingcompoundselucidatedbymcmdbaseddynamicdockingsimulations
AT fukunishiyoshifumi crypticsitebindingmechanismofmediumsizedbclxlinhibitingcompoundselucidatedbymcmdbaseddynamicdockingsimulations
AT kamiyanarutoshi crypticsitebindingmechanismofmediumsizedbclxlinhibitingcompoundselucidatedbymcmdbaseddynamicdockingsimulations